Moreover, ASPSCR1-TFE3 in alveolar soft part sarcomas and papillary renal cell carcinomas, and YAP1-TFE3 in epithelioid hemangioendotheliomas have been demonstrated [2]. This evidence concerns the gene YAP1 and epithelioid hemangioendothelioma.